Search results for "Secondary prevention"
No sex-specific differences seen in effectiveness, safety of aspirin for secondary prevention
Both men and women with atherosclerotic cardiovascular disease had similar rates of ischemic events on a daily aspirin dose of 81 mg versus 325 mg, according to a new analysis of an open-label randomized trial for secondary prevention.
https://immattersacp.org/weekly/archives/2024/07/16/4.htm
16 Jul 2024
Take TIAs as seriously as a stroke
Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://immattersacp.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023
Intensive statin therapy after stroke associated with higher risk of hemorrhage
No difference was found in risk of stroke recurrence between moderate- and high-intensity statin therapy, but the latter resulted in a higher risk for intracranial hemorrhage, a Chinese study found.
https://immattersacp.org/weekly/archives/2024/07/16/2.htm
16 Jul 2024
Statins not commonly used among younger cohorts even after ASCVD diagnosis
Among patients ages 18 to 44 years diagnosed with atherosclerotic cardiovascular disease (ASCVD), statin use changed from 18.34% in 1999 to 16.63% in 2020, according to data from the National Health and Nutrition Examination Survey.
https://immattersacp.org/weekly/archives/2024/08/20/4.htm
20 Aug 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://immattersacp.org/weekly/archives/2020/10/20/5.htm
20 Oct 2020
New drugs for diabetes, secondary prevention of CV events
This update covers approval of a new drug to treat type 2 diabetes mellitus, along with diet and exercise, and of a drug to reduce risk of heart attack, stroke, cardiovascular death, and need for revascularization in patients with a previous heart attack or peripheral artery disease.
https://immattersacp.org/archives/2014/07/fda.htm
1 Jul 2014
Discontinuing OAC associated with heightened risk of recurrent stroke, study finds
Among patients with atrial fibrillation prescribed oral anticoagulation (OAC) after a stroke, recurrent stroke rates were 13.4% versus 6.8% in those who did and did not discontinue OAC therapy, a Danish study found.
https://immattersacp.org/weekly/archives/2024/07/02/4.htm
2 Jul 2024
Self-administered aspirin immediately after myocardial infarction saves lives, study finds
Taking aspirin within four hours of severe chest pain onset and continuing treatment for 28 days after an acute myocardial infarction delayed 13,016 deaths annually, even after accounting for 963 deaths due to bleeding, researchers estimated.
https://immattersacp.org/weekly/archives/2024/05/07/4.htm
7 May 2024
Timing of stroke treatment, preventive therapies presented at stroke meeting
Results of multiple studies examining transfers of acute stroke patients for thrombectomy, delayed use of thrombolysis plus thrombectomy or tenecteplase, and anticoagulation for secondary prevention after cryptogenic stroke were reported at the International Stroke Conference.
https://immattersacp.org/weekly/archives/2024/02/13/2.htm
13 Feb 2024